2,4-Diaminothienopyrimidines as Orally Active Antimalarial Agents
Journal of Medicinal Chemistry2014Vol. 57(3), pp. 1014–1022
Citations Over TimeTop 15% of 2014 papers
Diego González Cabrera, Claire Le Manach, Frédèric Douelle, Yassir Younis, Tzu‐Shean Feng, Tanya Paquet, Aloysius T. Nchinda, Leslie J. Street, Dale Taylor, Carmen De Kock, Lubbe Wiesner, Sandra Duffy, Karen L. White, K. Mohammed Zabiulla, Yuvaraj Sambandan, Sridevi Bashyam, David Waterson, Michael J. Witty, Susan A. Charman, Vicky M. Avery, Sergio Wittlin, Kelly Chibale
Abstract
A novel series of 2,4-diaminothienopyrimidines with potential as antimalarials was identified from whole-cell high-throughput screening of a SoftFocus ion channel library. Synthesis and structure-activity relationship studies identified compounds with potent antiplasmodial activity and low in vitro cytotoxicity. Several of these analogues exhibited in vivo activity in the Plasmodium berghei mouse model when administered orally. However, inhibition of the hERG potassium channel was identified as a liability for this series.
Related Papers
- → Environment-Sensitive Fluorescent Probe for the Human Ether-a-go-go-Related Gene Potassium Channel(2016)32 cited
- Biosynthesis regulation and drug development for human ether-a-go-go related gene potassium channel:research advances(2013)
- Second messenger modulation of the human ether a go-go related gene (HERG) potassium channel(2005)
- → How to Fluorescently Label the Potassium Channel: A Case in hERG(2018)